Biogen Escapes Negligence Suit Over MS Drug Labeling
Biogen Idec Inc. and Elan Pharmaceuticals LLC escaped a suit alleging that the companies failed to sufficiently warn consumers that taking multiple sclerosis drug Tysabri increased their risk of developing a...To view the full article, register now.
Already a subscriber? Click here to view full article